Showing results (61-70 of 108) with videos related to
Sort By:
Pageof 11
Journal of Clinical Microbiology|March 26, 2010
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida speciesM A Pfaller, M Castanheira, D J Diekema, et al.Journal of Clinical Microbiology|January 27, 2012
Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrataM A Pfaller, M Castanheira, S R Lockhart, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999
Recurrent gram-negative bacteremia: incidence and clinical patternsC Wendt, S A Messer, R J Hollis, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999
Molecular epidemiology of gram-negative bacteremiaC Wendt, S A Messer, R J Hollis, et al.Diagnostic Microbiology and Infectious Disease|March 17, 2004
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance programM A Pfaller, S A Messer, L Boyken, et al.Journal of Clinical Microbiology|November 3, 2006
Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methodsM A Pfaller, S A Messer, L Boyken, et al.Journal of Clinical Microbiology|June 20, 2008
In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus speciesM A Pfaller, S A Messer, L Boyken, et al.Journal of Clinical Microbiology|December 17, 2010
Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilutionM A Pfaller, L Boyken, R J Hollis, et al.Journal of Clinical Microbiology|August 7, 2009
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007M A Pfaller, S A Messer, R J Hollis, et al.Journal of Clinical Microbiology|January 13, 2004
Evaluation of the NCCLS M44-P disk diffusion method for determining susceptibilities of 276 clinical isolates of Cryptococcus neoformans to fluconazoleM A Pfaller, S A Messer, L Boyken, et al.Pageof 11